There are not that many pharmas starting up new AD

There are not that many pharmas starting up new AD clinical trials every month. I suspect the number that are even in a position to begin making a decision on Lympro since we've been launched, can be counted on one hand. They might be waiting for Lympro's new biomarker to see how much it improves the multivariant numbers, or they might even be waiting for us to add the Georgetown blood tests to the suite before they begin a new trial. That might be another 5 months. It's hard to imagine that they would all postpone their trials until we add Georgetown, but our accuracy overall will go up immensely once we do. Most AD clinical trials have failed in the past....and one big reason is that the sample of people they were testing was not ideal, due to poor screening. Would the half a dozen or so pharmas scheduled to start trials in the next few months delay them another 6 months just so they could have our complete blood test suite to screen for them? I don't know. But it's possible.

If by July our 3 modalities are ready, 1) Cell Cycle, 2) Exosome, & 3) Lipid, even if none of those 3 are above 90% on a stand alone basis, when taken together their accuracy is above 99%!!!! That is HUGE!! Is this 99% accuracy for the 3 tests combined enough to slow down pharmas from starting up their trials until they can use all 3 with us? I don't know. But if their current screening is only 75% accurate and they are spending millions and millions of dollars on the trial, they might feel waiting 6 months to get 99% accuracy in their patients having AD..... is worth the wait.